Jove
Visualize
Contact Us

Related Concept Videos

Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a survival tree begins...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Receiver Operating Characteristic Plot01:15

Receiver Operating Characteristic Plot

A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum microRNA Profiles Reflect Differentiation Status and Age in Early Gastric Cancer.

Biomolecules·2026
Same author

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.

Frontiers in oncology·2025
Same author

Structure-Function Relationships in Geographic Atrophy Based on Mesopic Microperimetry, Fundus Autofluorescence, and Optical Coherence Tomography.

Translational vision science & technology·2025
Same author

Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts.

Journal of translational medicine·2024
Same author

Phase 2 Trial Evaluating Minocycline for Geographic Atrophy in Age-Related Macular Degeneration: A Nonrandomized Controlled Trial.

JAMA ophthalmology·2024
Same author

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.

Biomolecules·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 4, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data.

Richard M Simon1, Jyothi Subramanian, Ming-Chung Li

  • 1Biometric Research Branch, US National Cancer Institute, Bethesda, MD 20892-7434, USA. rsimon@nih.gov

Briefings in Bioinformatics
|February 18, 2011
PubMed
Summary

This study reviews methods for classifying patients into survival risk groups using whole genome data. It details how to use cross-validation to reliably evaluate these survival risk models, especially with limited data.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

  • Biostatistics
  • Genomics
  • Machine Learning

Background:

  • Whole genome biotechnology advancements necessitate robust statistical prediction methods.
  • Accurate classification of patients into survival risk groups is crucial for personalized medicine.
  • Existing methods for evaluating survival risk models often yield biased estimates with high-dimensional data.

Purpose of the Study:

  • To review and detail methodologies for classifying patients into survival risk groups.
  • To demonstrate the application of cross-validation for evaluating survival risk models, particularly with high-dimensional genomic data.
  • To address the challenges of biased estimates when using re-substitution statistics on limited datasets.

Main Methods:

  • Review of statistical methodologies for survival risk classification.
  • Application of cross-validation techniques for model evaluation.
  • Computation of cross-validated survival distributions and time-dependent ROC curves.
  • Evaluation of statistical significance and added predictive accuracy of genomic data.

Main Results:

  • Cross-validation provides reliable estimates for survival risk model evaluation, overcoming limitations of re-substitution statistics.
  • Methodology is presented for computing cross-validated survival distributions for predicted risk groups.
  • Cross-validated time-dependent ROC curves can be computed for robust model assessment.
  • Techniques for evaluating model significance and the contribution of high-dimensional genomic data are discussed.

Conclusions:

  • Cross-validation is essential for accurate evaluation of survival risk models, especially in high-dimensional genomic studies.
  • The presented methods enable reliable assessment of survival risk predictions even with limited data.
  • This work provides a framework for statistically rigorous evaluation of genomic-driven survival models.